Andere Sprachen Pyxis Oncology, Inc.

Aktien

A3C45M

US7473241013

PYXS

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:09:06 15.05.2024			% 5 Tage	% 1. Jan.
4,295 ^USD	+2,26 %		+1,17 %	+140,00 %

14.05.	Pyxis Oncology, Inc. ernennt Stephen Worsley zum Senior Vice President	CI
22.03.	PYXIS ONCOLOGY, INC. : HC Wainwright behält die Bewertung Kaufen bei	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Pyxis Oncology : RBC Capital Markets Global Healthcare Conference	13:01
Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M	14.05.
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024	14.05.
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024	14.05.
Pyxis Oncology, Inc. Appoints Stephen Worsley as its Senior Vice President	14.05.
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference	09.05.
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference	09.05.
Pyxis Oncology : Stifel 2024 Virtual Targeted Oncology Forum	17.04.
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	28.03.
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights	27.03.
Health Care Up on Drug Sales Optimism -- Health Care Roundup	21.03.
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023	21.03.
Pyxis Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21.03.
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA	13.03.
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA	13.03.
Pyxis Oncology, Inc. Appoints Santhosh Palani to Its Board of Directors	13.03.
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024	07.03.
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting	05.03.
Pyxis Oncology Announces Private Placement of Shares, Pre-Funded Warrants to Raise $50 Million	27.02.
Pyxis Oncology Announces $50 Million Private Placement	27.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Pyxis Oncology, Inc.

Aktien

A3C45M

US7473241013

PYXS

Andere Sprachen

Filter